FRANCE'S INNATE PHARMA SIGNS DEAL WITH SCHERING-PLOUGH

Privately held French biotech company Innate Pharma on Monday said it has signed a deal with U.S.-based Schering-Plough Corp. (SGP) to in-license some assets for developing toll-like receptors, or TLRs, which can help activate the body's adaptive immune system.
Market Watch